Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
EPR Properties
EPR
$4.7B
| $16.1M | 0.02% |
344,100
+42,400
| +14% | +$1.79M |
|
777
NRC Health Common Stock
NRC
$456M
| $16.1M | 0.02% |
369,584
+2,600
| +0.7% | +$114K |
|
778
TechTarget
TTGT
$265M
| $16M | 0.02% |
515,500
-5,000
| -1% | -$170K |
|
|
MFA
779
MFA Financial
MFA
$925M
| $16M | 0.02% |
1,427,325
-63,500
| -4% | -$676K |
|
780
Cincinnati Financial
CINF
$26.5B
| $16M | 0.02% |
164,700
-60,900
| -27% | -$6.29M |
|
781
Eversource Energy
ES
$26.9B
| $16M | 0.02% |
225,680
+131,900
| +141% | +$9.82M |
|
782
Bilibili
BILI
$7.37B
| $16M | 0.02% |
1,058,266
-1,017,800
| -49% | -$18.7M |
|
783
Broadridge
BR
$19.3B
| $16M | 0.02% |
+96,400
| New | +$14.6M |
|
784
Spok Holdings
SPOK
$230M
| $15.9M | 0.02% |
1,198,917
-17,105
| -1% | -$215K |
|
785
Sonoco
SON
$5.74B
| $15.9M | 0.02% |
269,852
+51,352
| +24% | +$3.09M |
|
786
MarketAxess Holdings
MKTX
$5.72B
| $15.9M | 0.02% |
60,810
-3,163
| -5% | -$944K |
|
787
Middlesex Water
MSEX
$1.1B
| $15.9M | 0.02% |
196,616
-14,484
| -7% | -$1.13M |
|
788
Synchrony
SYF
$25.8B
| $15.8M | 0.02% |
465,000
-276,500
| -37% | -$8.44M |
|
|
HOLI
789
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $15.8M | 0.02% |
896,570
-40,448
| -4% | -$661K |
|
790
Scotiabank
BNS
$110B
| $15.7M | 0.02% |
+313,600
| New | +$15.6M |
|
|
DHIL
791
DELISTED
Diamond Hill
DHIL
| $15.7M | 0.02% |
91,446
+2,400
| +3% | +$399K |
|
792
ATN International
ATNI
$478M
| $15.7M | 0.02% |
427,600
+2,600
| +0.6% | +$99.9K |
|
793
Varonis Systems
VRNS
$4.82B
| $15.6M | 0.02% |
586,300
-147,200
| -20% | -$3.68M |
|
794
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $15.6M | 0.02% |
331,900
-213,100
| -39% | -$10M |
|
|
CPRX
795
DELISTED
Catalyst Pharmaceutical
CPRX
| $15.5M | 0.02% |
1,154,900
+64,800
| +6% | +$933K |
|
796
STAAR Surgical
STAA
$1.27B
| $15.5M | 0.02% |
294,900
-1,800
| -0.6% | -$110K |
|
|
JKS
797
JinkoSolar
JKS
$860M
| $15.5M | 0.02% |
348,400
-28,778
| -8% | -$1.3M |
|
|
SEE
798
DELISTED
Sealed Air
SEE
| $15.4M | 0.02% |
385,709
-490,700
| -56% | -$20.9M |
|
799
Graco
GGG
$13.4B
| $15.4M | 0.02% |
178,600
-70,500
| -28% | -$5.48M |
|
800
Kilroy Realty
KRC
$4.22B
| $15.4M | 0.02% |
512,500
-19,900
| -4% | -$580K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.